| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Apr 7, 2026 | Option exercise(M) | 10K | — | — | 81K |
| Apr 7, 2026 | Tax withholding(F) | 5K | $48.94 | $236K | 76K |
| Apr 6, 2026 | Option exercise(M) | 7K | $10.36 | $75K | 7K |
| Apr 6, 2026 | Sell(S) | 7K | $50.01 | $364K | 0 |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Apr 7, 2026 | Option exercise(M) | 10K | — | $0 | 0 |
| Apr 6, 2026 | Option exercise(M) | 7K | — | $0 | 432K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001532218-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Kiniksa Pharmaceuticals International, plc
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.